Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 35, 2021 - Issue 24
192
Views
2
CrossRef citations to date
0
Altmetric
Short Communications

Bisbenzylisoquinoline alkaloids of Cissampelos sympodialis with antiviral activity against dengue virus

, , , , , , & ORCID Icon show all
Pages 6129-6133 | Received 15 Jun 2020, Accepted 05 Sep 2020, Published online: 29 Sep 2020
 

Abstract

A number of bisbenzyilisoquinoline alkaloids have been previously isolated from Cissampelos sympodialis (Menispermaceae). The tertiary alkaloid fraction of the rhizomes (TAFrz) was prepared and the major alkaloid warifteine was isolated. Five TAFrz subfractions in addition to warifteine were tested against Dengue virus (DENV). We then used an epithelial (Vero) cell line to evaluate the cytotoxicity and effective concentrations of the samples against DENV. All TAFrz subfractions were active, but subfraction 6 (a mixture of the alkaloids methylwarifteine and warifteine) in particular showed a promising antiviral effect against DENV-2 with an IC50 of 2.00 µg/mL and a selectivity index (SI) of 10.74. Warifteine was the second most active sample and had an IC50 of 8.13 µg/mL and SI = 10.94. The antiviral activity of the samples compared favorably with that of 6-methylmercaptopurine riboside (IC50 = 7.31 µg/mL and SI = 11.8). These results suggest that bisbenzylisoquinoline alkaloids may prove interesting leading antiviral compounds.

Acknowledgement

The authors are also grateful to Dr. Vicente Carlos de Oliveira Costa from Federal University of Paraiba, Brazil for NMR spectral data.

Disclosure statement

The authors have no conflicts of interest to disclose.

Additional information

Funding

The authors are grateful to FAPEMIG (research grant APQ-00523-15 for E. J. Oliveira and MSc grant of A. H. Fonseca). P. G. da Silva is a recipient of a MSc fellowship from the Pernambuco State Foundation for Science and Technology of Pernambuco (FACEPE). T. M. S. Da Silva is grateful to FACEPE (Grant no. PRONEM APQ-0741106/2014).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.